UroGen Pharma Ltd.·4

Sep 8, 3:41 PM ET

Kim Dong 4

4 · UroGen Pharma Ltd. · Filed Sep 8, 2023

Insider Transaction Report

Form 4
Period: 2023-09-07
Kim Dong
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2023-09-07+7,5007,500 total
    Ordinary Shares (7,500 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
  • [F2]1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4